Immunotherapy with CpG‐ODN in neoplastic meningitis: A phase I trial

E-ISSN： 1349-7006|106|9|1212-1218

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.9, 2015-09, pp. : 1212-1218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy with CpG‐ODN in neoplastic meningitis: A phase I trial

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1212-1218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I trial of volasertib, a Polo‐like kinase inhibitor, in Japanese patients with acute myeloid leukemia

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1590-1595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I/II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1414-1420

John Wiley & Sons Inc

Access to resources Recommend Favorite

CpG oligodeoxynucleotides potentiate the antitumor activity of anti‐BST2 antibody

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1474-1478

John Wiley & Sons Inc

Access to resources Recommend Favorite

2015 Guidance on cancer immunotherapy development in early‐phase clinical studies

Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. : 1761-1771

John Wiley & Sons Inc

Access to resources Recommend Favorite